Nexgel (NXGLW) Shares Outstanding (Diluted Average) (2018 - 2025)
Nexgel (NXGLW) reported Shares Outstanding (Diluted Average) of $7.9 million for Q4 2025, up 20.62% on a YoY basis from $6.5 million in Q4 2024, and down 1.47% quarter-over-quarter from $8.0 million in Q3 2025.
Nexgel (NXGLW) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends
Nexgel has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $7.9 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 20.62% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (up 20.62% YoY), and the FY2025 full-year result was $7.9 million, up 20.62% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $7.9 million, down from $8.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $5.6 billion in Q1 2022, with the low at $2.9 million in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $711.1 million across 5 years, with a median of $6.1 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) jumped 193851.22% — and 2023, when it tumbled 99.9%.
- Nexgel's Shares Outstanding (Diluted Average) stood at $3.0 million in 2021, then surged by 87.08% to $5.6 million in 2022, then increased by 1.74% to $5.7 million in 2023, then gained by 14.81% to $6.5 million in 2024, then advanced by 20.62% to $7.9 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $7.9 million (Q4 2025), $8.0 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 | 7.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.85 Mn |
| Sep 30, 2025 | 7.97 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 7.65 Mn |
| Dec 31, 2024 | 6.51 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 5.59 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 5.57 Mn |
| Jun 30, 2022 | 5.57 Bn |
| Mar 31, 2022 | 5.57 Bn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.98 Bn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 2.87 Mn |